Study : Actualité Study en direct - P4 | Bourse Reflex
Accueil > Tags > Study

  • Toutes les actualités en rapport avec « Study »

05/01 18:00 Study - Patient enrolment 100% completed for Phase IIa trial for high blood pressure

16/11 18:30 Study - Q3 2015 Financial information

16/11 10:30 Study - Tradelab remporte 4 trophées aux MarCom USA et aux Marketing Effectiveness Awards

29/10 18:00 Study - Genticel Announces First Patient Treated in U.S. Phase 1 Clinical Trial of GTL001, Company's Therapeutic Vaccine Candidate against HPV 16/18 Infections

28/10 18:45 Study - Business Update - Third Quarter 2015

06/10 18:00 Study - Positive opinion from Monitoring Board to continue protocol as planned, for Phase IIa clinical trial under way for high blood pressure

21/09 17:40 Study - Genticel presents first half 2015 financial results, operational progress and outlook

08/09 18:00 Study - Phase IIa clinical trial for high blood pressure : 50% enrolment four months ahead of schedule and Supervisory Board meeting coming up

10/08 18:00 Study - New EUR 18 million financing aimed at accelerating the development in connected health, particularly in the USA

28/07 18:00 Study - Business Update - Second Quarter 2015

27/07 18:00 Study - Quantum Genomics announces the appointment of Professor Faiez Zannad as its heart failure consultant

07/07 18:00 Study - Independent Data Safety Monitoring Board Recommends Continuation per Protocol of Genticel's Phase 2 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

29/06 18:45 Study - Quantum Genomics obtains positive results with heart failure study in dogs

16/06 07:00 Study - Genticel Receives FDA Clearance of IND Application for U.S. Phase 1 Clinical Trial of GTL001 (ProCervix), Company's First-in-class HPV Therapeutic Vaccine Candidate

27/05 18:00 Study - Naturex reorganises its manufacturing operations serving the pharmaceutical market

28/04 19:00 Study - Business Update - First Quarter 2015

22/04 18:45 Study - 2014 Annual financial report now available - Update on Q1 2015 activity

22/04 18:30 Study - 2014 Annual financial report now available - Update on Q1 2015 activity

20/04 18:40 Study - Genticel to Present Further Promising Pharmacology In-Vivo Results of its Phase 2 Immunotherapeutic Vaccine Candidate, GTL001 (ProCervix), at AACR Annual Meeting 2015

03/03 17:45 Study - First patients recruited for Phase IIa trial of drug candidate QGC001